Table 1. Patient characteristics and type of method.
| Control | CRSsNP | CRSwNP | ||
| Total no. of subjects | N = 18 (5 male) | N = 45 (23 male) | N = 56 (35 male) | |
| Tissue used | UP | UP | UP | NP |
| Age (yr), mean (SD) | 41 (19) | 49 (12) | 49 (13) | 46 (16) |
| Allergic rhinitis, N (%) | 0 (0%) | 16 (35%) | 7 (36%) | 16 (37%) |
| Asthma, N | 0 | 0 | 0 | 0 |
| Aspirin sensitivity, N | 0 | 0 | 0 | 0 |
| Lund-Mackay CT score | 0 (0) | 8.8 (5.0) | 14.0 (6.5) | 15.2 (6.6) |
| Lund-Kennedy score | NA | 0.9 (1.6) | 3.2 (2.5) | 3.4 (2.8) |
| Blood eosinophil (%) | 3.6 (2.3) | 5.4 (3.8) | 4.1 (3.6) | 3.6 (3.4) |
| Polyp characteristics (Eosinophilic/Non-eosinophilic) | NA | NA | NA | 22/34 |
| Methodologies used | ||||
| Tissue IHC | 18 | 45 | 56 | 56 |
| FACS | 0 | 10 | 0 | 11 |
| Tissue mRNA | 18 | 25 | 19 | 25 |
| Tissue homogenates | 7 | 13 | 14 | 30 |
Lund-Kennedy score was evaluated at postoperative 6 months.